Hantaviruses are negative-sense single-stranded RNA viruses belonging to the Bunyaviridae family. Different species of hantavirus have specific rodent hosts that each virus type associates with. Deer mice, cotton rats and voles function as virus reservoirs because they transmit the virus through bodily fluids without showing symptoms. Human infection occurs when people inhale airborne particles containing the virus which originate from dried waste from rodents. People get infected less often through direct interaction with infected rodents or their excrement or bites from these rodents.
Figure 1. Hantavirus. (Vaheri, Antti, et al., 2013)
Among the various conditions human hantavirus infections cause hantavirus pulmonary syndrome emerges as the most severe. The first recognized outbreak of HPS occurred in the southwestern United States during 1993 when a healthy young Navajo man and his fiancée both died from the disease. After HPS was first discovered it spread to numerous regions across North America and throughout Central and South America.
Figure 2. Hantavirus Pulmonary Syndrome (HPS). (Singh, Pratibha, et al., 2014)
The development of HPS occurs through a complex response from the immune system. After inhalation, the virus circulates through the bloodstream to infect endothelial cells that line blood vessels. The disease causes blood vessels to become more permeable which leads to fluid leaking from them into lung tissue and other areas of the body. Severe respiratory distress emerges as the main symptom patients show when affected by HPS. Early-stage HPS patients usually experience symptoms similar to the flu such as fever and headache along with muscle pain fatigue and nausea. The initial symptoms of this condition may often be confused with signs of general illnesses. A few days after onset patients enter the cardiopulmonary phase which causes rapid breathing and shortness of breath together with low blood pressure. Respiratory failure emerges from lung fluid accumulation that impedes oxygen exchange and ultimately becomes fatal without prompt medical intervention.
HPS exerts its main effects on the respiratory system and heart function. When the virus penetrates endothelial cells that line blood vessels it leads to fluid accumulation and leakage within the lungs. Key complications include:
Hantavirus Pulmonary Syndrome requires timely diagnosis and proper patient management because it attacks the respiratory system unlike Hantavirus Fever with Renal Syndrome which targets the kidneys.
While most viral diseases transmit easily among people, hantaviruses are generally not contagious among humans with the exception of the Andes virus which transmits infrequently among humans. Direct contact with rodents that carry the virus or their bodily waste results in human infections. The primary way humans contract infections from this virus is by breathing in particles that enter the air. When rodent urine and waste materials dry out their viral particles become airborne. People who clean rodent-contaminated areas such as sheds, barns or cabins create aerosols which they can inhale and which carry the virus.
Figure 3. Transmission of Hantavirus. (Singh, Pratibha, et al., 2014)
Other less common routes of transmission include:
HPS develops through several phases with symptoms emerging between 1 and 8 weeks following exposure. Medical professionals categorize the progression of this disease into three distinct stages.
| Phase | Symptoms |
| Early Symptoms (Prodromal Phase) | In the beginning stages patients experience flu-like symptoms which can manifest as:
|
| Cardiopulmonary Phase (Severe Respiratory Distress) | The disease advances quickly to severe respiratory symptoms within 4–10 days.
|
| Recovery Phase | Survivors of the critical phase often face extended periods of fatigue while needing multiple weeks or months to regain full health. Lasting complications in the lungs or heart may develop in some patients. |
HPS exerts its main effects on the respiratory system and heart function. When the virus penetrates endothelial cells that line blood vessels it leads to fluid accumulation and leakage within the lungs. Key complications include:
ARDS is a serious lung condition which occurs when fluid accumulates in the air sacs blocking oxygen transfer to the bloodstream.
The leakage of blood from vessels results in dangerously low blood pressure leading to hypotension and shock.
The heart may develop irregular rhythms and decreased functionality as cardiac complications.
Hantavirus Pulmonary Syndrome affects the respiratory system instead of the kidneys like Hantavirus Fever with Renal Syndrome while requiring quick diagnosis and proper patient care.
Different strains of hantavirus cause infections across the world, with specific strains dominating in distinct regions. For example:
HPS primarily affects regions in Asia, Europe, and the Americas and usually emerges in rural and semi-rural habitats that have high rodent populations
Supportive care forms the fundamental approach to treating HFRS by concentrating on fluid balance control alongside blood pressure and kidney function management.
Hantaviruses represent a major public health challenge because they can induce serious and life - threatening diseases. Early diagnosis and proper management of hantavirus diseases depends on comprehensive knowledge of hantavirus characteristics and treatment options through understanding their transmission and symptoms. Research into antiviral therapies and enhanced prevention methods must continue to effectively address the danger these viruses present.
References
| Cat. No. | Product Name | Size | Species Reactivity | Application | Detection Method | |
| DEIABL10 | Mouse Anti-Hantavirus ELISA Kit | 2×48T | Mouse | Qualitative | sELISA | Inquiry |
| DEIA-JY2451 | Mouse Hantavirus (HV) Antibody ELISA Kit | 96T | Mouse | Qualitative | iELISA | Inquiry |
| DEIA-JY2467 | Rat Hantavirus (HV) Antibody ELISA Kit | 96T | Rat | Qualitative | iELISA | Inquiry |
| DEIA2203L | Human Hantavirus Nucleoprotein (HVNP) IgG/IgM ELISA Kit | 96T | Human | Qualitative | iELISA | Inquiry |
| Cat. No. | Product Name | Size | Species Reactivity | Application | Detection Method | |
| PCR-NS2618 | Andes virus Real Time PCR Kit | 50 Reactions | Andes virus | Qualitative | Real-Time PCR | Inquiry |
| PCR-WN-151 | Hantavirus Real Time PCR Kit | 50 Reactions | Hantaan, Seoul, and Puumala | Qualitative | Real-Time PCR | Inquiry |
| Cat. No. | Product Name | Size | Reference Range | |
| NA-GWP-SR-38-L1 | Andes virus (Hantavirus Pulmonary Syndrome (HPS)) Nucleic Acid Standard Reference | 1mL/vial | 1.6×10^3~1.6×10^4 copies/mL | Inquiry |
| NA-GWP-SR-38-S1 | Andes virus (Hantavirus Pulmonary Syndrome (HPS)) Nucleic Acid Standard Reference | 1mL/vial | 6.3×10^2~6.3×10^3 copies/mL | Inquiry |
| NA-GWP-SR-38-S2 | Andes virus (Hantavirus Pulmonary Syndrome (HPS)) Nucleic Acid Standard Reference | 1mL/vial | 3.2×10^2~3.2×10^3 copies/mL | Inquiry |
| NA-GWP-SR-38-S3 | Andes virus (Hantavirus Pulmonary Syndrome (HPS)) Nucleic Acid Standard Reference | 1mL/vial | 1.6×10^2~1.6×10^3 copies/mL | Inquiry |